Systems Immunology & Immunoengineering:

A Proposal for Using CAR T-Cell AND Gates with MUC1 and MSLN Receptors to Treat Pancreatic Adenocarcinoma (Click Here).

  • My team was tasked with modeling a novel application of T-cell engineering based on literature review.

  • I came up with the idea of pancreatic adenocarcinoma treatment and mathematically modeled the combinatorial CCR T-cell therapy we chose.

  • We presented in front of the entire class.